Physicians' views and practices concerning menopausal hormone therapy

Maturitas

Volumn 56, Issue 1, 2007, Pages 30-37

  Sangi Haghpeykar, Haleh ^a   Poindexter III, Alfred N ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Estrogen + progestogen therapy; Menopause; Physicians' views

Indexed keywords

ESTROGEN; PROGESTERONE;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BREAST CANCER; BREAST EXAMINATION; CEREBROVASCULAR DISEASE; DRUG CONTRAINDICATION; ESTROGEN THERAPY; HEALTH SURVEY; HORMONAL THERAPY; ISCHEMIC HEART DISEASE; MAMMOGRAPHY; MEDICAL PRACTICE; MENOPAUSAL SYNDROME; PELVIS; QUESTIONNAIRE; THROMBOSIS; UNITED STATES; UTERUS CANCER;

ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MENOPAUSE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; SPECIALTIES, MEDICAL; UNITED STATES;

EID: 33845406349     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2006.05.003     Document Type: Article

References (40)

1. Finley C., Gregg E.W., Solomon L.J., and Gay E. Disparities in hormone replacement therapy use by socioeconomic status in a primary care population. J Commun Health 26 (2001) 39-50
2. Vihtamaki T., Savilahti R., and Tuimala R. Why do postmenopausal women discontinue hormone replacement therapy?. Maturitas 33 (1999) 99-105
3. Rabin D.S., Cipparrone N., Linn E.S., and Moen M. Why menopausal women do not want to take hormone replacement therapy. Menopause 6 (1999) 61-67
4. Sogaard A.J., Tollan A., Berntsen G.K., Fonnebo V., and Mangus J.H. Hormone replacement therapy: knowledge, attitudes, self-reported use, and sales figures in Nordic women. Maturitas 35 (2000) 201-214
5. Griffiths F. Women's decisions about whether or not to take hormone replacement therapy: influence of social and medical factors. Br J Gen Pract 45 (1995) 477-480
6. Schneider H.P. Cross-national study of women's use of hormone replacement therapy (HRT) in Europe. Int J Fertil Womens Med 42 (1997) 365-375
7. Rothert M., Padonu G., Holmes-Rovner M., et al. Menopausal women as decision makers in health care. Exp Gerontol 29 (1994) 463-468
8. Miller J., Chan B.K., and Nelson H.D. Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the US Preventive Services Task Force. Ann Intern Med 136 (2002) 680-690
9. Grodstein F., Colditz G., and Stampfer M. Postmenopausal hormone use and cholecystectomy in a large prospective study. Obstet Gynecol 83 (1994) 5-11
10. Uhler M.L., Marks J.W., and Judd H.L. Estrogen replacement therapy and gallbladder disease in postmenopausal women. Menopause 7 (2000) 162-167
11. Bergkvist L., Adami H.O., Persson I., Hoover R., and Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 32 (1989) 293-297
12. Colditz G.A., Hankinson S.E., Hunter D.J., et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332 (1995) 1589-1593
13. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280 (1998) 605-613
14. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen and progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA Express 288 (2002) 321-333
15. Shumaker S.A., Legault C., Rapp S.R., et al. For the WHIMS investigators estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The women's health initiative memory study: a randomized controlled trial. JAMA 289 (2003) 2651-2662
16. Ena G., and Rozenberg S. Issues to debate on the women's health initiative (WHI) study. Prescription attitudes among Belgian gynecologists after premature discontinuation of the WHI study. Hum Reprod 18 11 (2003) 2245-2248
17. Blumel J.E., Castelo-Branco C., Chedraui P.A., et al. Patients' and clinicians' attitudes after the Women's Health Initiative study. Menopause 11 (2004) 57-61
18. Nassar A.H., Essamad H.M., Awwad J.T., Khoury N.G., and Usta I.M. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era. Maturitas 52 (2005) 18-25
19. Kaplan B., Yogev Y., Orvieto R., Hirsch M., Fisher M., and Rabinerson D. Effect of the WHI study on the attitude of Israeli gynecologists to hormonal therapy during menopause. Clin Exp Obstet Gynecol 31 (2004) 267-268
20. Moen M.H., Nilsen S.T., and Iversen O.E. A significant change in Norwegian gynecologist's attitude to hormone therapy is observed after the results of the women's health initiative study. Acta Obstet Gynecol Scand 84 (2005) 92-93
21. Thunell L., Milsom I., Schmidt J., and Mattsson L.A. Scientific evidence changes prescribing practice-a comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynecologists in 1996 and 2003. BJOG: Int J Obstet Gynecol 113 (2006) 15-20
22. Ringa V., Legare F., Dodin S., Norton J., Godin G., and Breart G. Hormone therapy prescription among physicians in France and Quebec. Menopause 11 (2004) 89-97
23. Rolnick S.J., Kopher R.A., Compo R.B., Kelly M.E., and Defor T.A. Provider attitudes and self reported behaviors related to hormone replacement therapy. Menopause 6 (1999) 257-263
24. Exline J.L., Siegler I.C., and Bastian L.A. Differences in providers' beliefs about benefits and risks of hormone replacement therapy in managed care. J Women's Health 7 (1998) 879-884
25. Stafford R.S., Saglam D., Causino N., and Blumenthal D. Low rates of hormone replacement in visits to United States primary care physicians. Am J Obstet Gynecol 177 (1997) 381-387
26. Kaplan B., Aschkenazi-Steinberg S., Yogev Y., Nahum R., Sulkes J., and Phisher M. Gynecologists' trends and attitudes toward prescribing hormone replacement therapy during menopause. Menopause 9 (2002) 354-359
27. Anderson G.L., Limacher M., Assaf A.F., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women's health initiative randomized controlled trial. JAMA 291 (2004) 1701-1712
28. Menopause and hormone therapy: treatment and talking to your doctor, 2006, http://www.4women.gov/menopause/.
29. Kaplan B., Robinerson D., Yogev Y., Bar-Hava I., Bar J., and Orvieto R. A survey of physicians' attitude and approach to hormone replacement therapy during menopause. Clin Exp Obstet Gynecol 29 (2002) 31-33
30. Nanda K., Bastian L.A., Hasselblad V., and Simel D.L. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstet Gynecol 93 (1999) 880-888
31. Beral V., Banks E., and Reeves G. Evidence from randomized trials on the long-term effects of hormone replacement therapy. Lancet 360 (2002) 942-944
32. Hendrix S.L., Cochrane B.B., Nygaard I.E., et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 293 (2005) 935-948
33. Norman S.G., and Studd J.W. A survey of views on hormone replacement therapy. Br J Obstet Gynaecol 101 (1994) 879-887
34. Trinh X.B., Van Hal G., Weyler J., and Tjalma W.A. The thoughts of physicians regarding the need to start hormone replacement therapy in breast cancer survivors. Eur J Obstet Gynecol Reprod Biol 124 (2006) 207-211
35. Ghali W.A., Freund K.M., Boss R.D., Ryan C.A., and Moskowitz M.A. Menopausal hormone therapy: physician awareness of patient attitudes. Am J Med 103 (1997) 3-10
36. Hemminki E., Topo P., Malin M., and Kangas I. Physicians' views on hormone therapy around and after menopause. Maturitas 16 (1993) 163-173
37. Keating N.L., Cleary P.D., Aossi A.S., Zaslavsky A.M., and Ayanian J.Z. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med 139 (1999) 545-553
38. Ness J., Aronow W.S., Newkirk E., and McDanel D. Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial. J Geronotol A Biol Sci Med Sci 60 (2005) 460-462
39. Ness J., Aronow W.S., and Beck G. Menopausal symptoms after cessation of hormone replacement therapy. Maturitas 53 (2006) 356-361
40. Sherman S., Miller H., Nerurkar L., and Schiff I. Research opportunities for reducing the burden of menopause-related symptoms. Am J Med 118 (2005) 166-171